MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY:JNJ)

239.99 +2.20 (+0.93%)
Official Closing Price Updated: 7:00 PM EST, Feb 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 8,274,034
Open 238.96
Bid (Size) 239.03 (200)
Ask (Size) 239.88 (100)
Prev. Close 237.79
Today's Range 237.98 - 240.94
52wk Range 141.50 - 240.94
Shares Outstanding 2,628,679,824
Dividend Yield 2.17%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
What is Considered a Good Stock Dividend? 2 Healthcare Stocks That Fit the Bill. ↗
These companies pay very healthy dividends. 
Via The Motley Fool
Topics Bonds
Johnson & Johnson (NYSE:JNJ) Stands Out as a High-Quality Dividend Aristocrat for Income Investors ↗
Via Chartmill

Performance

YTD
+15.7%
+15.7%
1 Month
+16.6%
+16.6%
3 Month
+27.4%
+27.4%
6 Month
+38.1%
+38.1%
1 Year
+56.7%
+56.7%

More News

Read More
News headline image
Johnson & Johnson Presents Early Outcomes from the OMNY-AF Pilot Study at 2026 AF Symposium
From Johnson & Johnson
Via Business Wire
News headline image
Eli Lilly Booms, Then Busts: Stellar Guidance vs Hims Undercut ↗
Via MarketBeat
Johnson & Johnson's Getting Back to Double-Digit Growth. Has the Stock Become a Bargain Buy? ↗
Via The Motley Fool
News headline image
Johnson & Johnson Is A Resilient Blue-Chip Stock And It Just Hit New All-Time Highs ↗
Via Talk Markets
News headline image
Johnson & Johnson Is a Resilient Blue-Chip Stock and It Just Hit New All-Time Highs
Via Barchart.com
News headline image
The Great Pipeline Grab: Life Sciences Deal Volume Skyrockets 82% as Big Pharma Battles the Patent Cliff
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
News headline image
Roivant Sciences (ROIV): Anatomy of a 15% Surge and the Future of the ‘Vant’ Model
Via Finterra
Topics ETFs Economy Initial Public Offering
News headline image
The $14.5 Billion Homecoming: Boston Scientific Reclaims the Neurovascular Throne with Penumbra Acquisition
Via MarketMinute
Topics Supply Chain
News headline image
Navigating the MedTech Correction: A Deep-Dive into Boston Scientific (NYSE: BSX)
Via Finterra
Topics Product Recall World Trade
News headline image
The Pharma Reckoning: 2026 Earnings Unveil a New Era of 'TrumpRx' Deals and Looming Patent Cliffs
Via MarketMinute
Topics Economy Government Intellectual Property
News headline image
Johnson & Johnson to Participate in the TD Cowen 46th Annual Health Care Conference
From Johnson & Johnson
Via Business Wire
News headline image
The Biological Singularity: How AlphaFold 3 Is Rewriting the Blueprint of Drug Discovery
Via TokenRing AI
Topics Artificial Intelligence
News headline image
Where Will AbbVie Be in 5 Years? ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
All It Takes Is $13,000 Invested in Each of These 2 Dividend Kings to Help Generate $1,000 in Passive Income in 2026 ↗
Via The Motley Fool
Topics Earnings
News headline image
3 Vanguard ETFs to Buy to Protect Your Portfolio from a Potential Stock Market Crash ↗
Via The Motley Fool
Topics Bonds ETFs Regulatory Compliance
News headline image
Looking for Passive Income in 2026? 3 Dividend Kings to Buy Hand Over Fist ↗
Via The Motley Fool
News headline image
1 Super-Safe High-Yield Dividend King Stock to Buy Even if There's a Stock Market Sell-Off in 2026 ↗
Via The Motley Fool
Topics Artificial Intelligence Economy World Trade
News headline image
This Top Dividend Stock Could Achieve a Major Milestone This Year. Is It a Buy? ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Economic Alarm Bells: LEI Index Slips 0.3% as US Economy Navigates a Fragile 2026 Start
Via MarketMinute
Topics Artificial Intelligence Economy World Trade
News headline image
What Are Wall Street Analysts' Target Price for Johnson & Johnson Stock?
Via Barchart.com
Topics ETFs World Trade
News headline image
TSM or NVDA? ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
The Biological Singularity: How Nobel-Winning AlphaFold 3 is Rewriting the Blueprint of Life
Via TokenRing AI
Topics Artificial Intelligence Economy
News headline image
Boston Scientific to Acquire Penumbra for $14.5 Billion in Massive MedTech Consolidation
Via MarketMinute

Frequently Asked Questions

Is Johnson & Johnson publicly traded?
Yes, Johnson & Johnson is publicly traded.
What exchange does Johnson & Johnson trade on?
Johnson & Johnson trades on the New York Stock Exchange
What is the ticker symbol for Johnson & Johnson?
The ticker symbol for Johnson & Johnson is JNJ on the New York Stock Exchange
What is the current price of Johnson & Johnson?
The current price of Johnson & Johnson is 239.99
When was Johnson & Johnson last traded?
The last trade of Johnson & Johnson was at 02/06/26 07:00 PM ET
What is the market capitalization of Johnson & Johnson?
The market capitalization of Johnson & Johnson is 630.86B
How many shares of Johnson & Johnson are outstanding?
Johnson & Johnson has 631B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story